Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Category list : Drug packaging

Sort by: Newest first Oldest first A-Z Z-A

  • A retrograde step to 30-day packs Subscription

    19 APR 2014 By Peter McAuley

    I note with dismay the announcement in the PJ that the Femara packaging has been switched from a 28-pack to 30-day pack. (PJ 2014;292:292).

  • The blister packs of drugs for people with Alzheimer’s disease will be marked with days of the week in order to reduce confusion. George Freeman (pictured) said the move reflects the government's aim to make the UK a world-leader in dementia care

    Blister packs for Alzheimer's drugs to be redesigned to reduce confusion for patients Subscription

    4 NOV 2015 16:57
    Comments (2)

    The blister packs of drugs for people with Alzheimer’s disease will, from summer 2016, be marked with days of the week in order to reduce confusion when patients take their medicine, the UK medicines safety regulator has announced.

  • Canesten range updated Subscription

    21 SEP 2015 11:58

    Bayer is updating its range of Canesten products. There will be changes to the naming and packaging, with the updated products being introduced from July 2015 until early 2016. The active ingredients and product composition will remain the same.

  • Blank or white medicine blister pack

    Design for dispensing: how far can we go to make packaging safer? Subscription

    18 MAY 2017 13:26 By Emma Wilkinson
    Comments (2)

    It is a decade since the National Patient Safety Agency issued guidance on medicines packaging design in a bid to reduce the risk of dispensing errors. But medicines that sound alike or look alike are still responsible for a large proportion of errors. A collaborative approach between manufacturers, regulators and pharmacy organisations is required to tackle the problem.

  • Medicine packets on shelf

    EMA orders medicine name changes for first time to reduce errors

    2 AUG 2019 11:45
    Comments (1)

    For the first time, drug companies across Europe have been told to change the names of medicines containing liposomal in their drug delivery systems following reports of medication errors that have led to patient deaths.

  • Malcolm Harrison, chief executive of the Company Chemists Association

    Exclude medicines packaging from single-use plastics tax, urges CCA

    4 JUN 2018 10:59 By Kathy Oxtoby

    The Company Chemists’ Association (CCA) has called on Her Majesty’s (HM) Treasury for all medicine-related items to be excluded from its definition of single-use plastics in new efforts to address waste.

  • Imodium-loperamide-blister-pack-short-term-use

    FDA calls for label change on anti-diarrhoea drug to stem misuse by opioid users

    2 FEB 2018 14:14

    US Food and Drug Administration calls for changes to how loperamide is packaged so that it can be sold in smaller quantities, for short-term use only.

  • GlaxoSmithKline will change colour of Relvar Ellipta inhaler from blue to yellow after respiratory health professionals warned that patients could be confused

    GlaxoSmithKline revises colour and labelling of Relvar Ellipta inhaler Subscription

    10 DEC 2014 10:07 By Ingrid Torjesen

    GlaxoSmithKline is changing the colour of its Relvar Ellipta inhaler from blue to yellow after respiratory health professionals warned that patients could be confused.

  • Clinician involvement in the design of drug packaging would help reduce look-alike medicines and reduce the risk of dispensing errors and patient harm. In the image, medicine shelves stacked with different drugs

    How lookalike medicines can cause harm to patients Subscription

    15 OCT 2015 13:56 By Vanessa Redmond

    Involving clinicians in the design of drug packaging would help reduce the number of lookalike medicines and lower the risk of dispensing errors and patient harm.

  • Improving packaging safety Subscription

    7 JUN 2017 12:21 By Gordon Urquhart

    In Emma Wilkinson’s excellent feature on pharmaceutical packaging design (The Pharmaceutical Journal 2017;298:281), she stated that tall man lettering was introduced in 2009 following research by the National Patient Safety Agency (NPSA). The packaging for Wockhardt UK Ltd’s cephalosporin range was approved by the Medicines and Healthcare products Regulatory ...

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.